Author Archives: rtushnet

Selling scammy books is protected by the First Amendment when selling scammy products isn’t

Federal Trade Comm’n v. Agora Financial, LLC, 2020 WL 998734, No. 1:19-cv-3100-SAG (D. Md. Mar. 2, 2020) The defendants do relatively well here by selling scammy and deceptive books. To the extent that the deception is contained in the books, … Continue reading

Posted in Uncategorized | Tagged , , , | Leave a comment

negative inference about other juices from “no sugar added” on D’s juice is implausible

Shaeffer v. Califia Farms, LLC, 44 Cal.App.5th 1125, No. B291085 (Feb. 6, 2020) Califia sells a “100% Tangerine Juice.” The front label includes “100% Tangerine Juice,” “No Sugar Added,” and “Never From Concentrate.” Shaeffer brought the usual California claims, alleging … Continue reading

Posted in Uncategorized | Tagged , , | Leave a comment

commercial advertising & promotion post-Lexmark: 10th Circuit preserves old test

Strauss v. Angie’s List, Inc., — F.3d —-, 2020 WL 1126523, No. 19-3025 (10th Cir. Mar. 9, 2020) Lexmark, most courts have recognized, changed prong 2 of the standard Gordon & Breach test for “commercial advertising or promotion.” Unfortunately, the … Continue reading

Posted in Uncategorized | Tagged | Leave a comment

“complete” vitamin is plausibly deceptive where essential nutrients are lacking

Devane v. Church & Dwight Co., No. 3:19-cv-09899-BRM-LHG, 2020 WL 998946 (D.N.J. Feb. 28, 2020) Plaintiffs brought consumer protection claims based on Church & Dwight’s purportedly false labelling of several multivitamins, including L’il Critters Multivitamins, Vitafusion Women’s Complete Multivitamins, and … Continue reading

Posted in Uncategorized | Tagged , , | Leave a comment

discovery of trade secrets in a false advertising case

Monster Energy Co. v. Vital Pharm., Inc., 2019 WL 8112506, No. 5:18-cv-01882-JGB (SHKx) (C.D. Cal. Oct. 16, 2019) I don’t cover many discovery disputes, but this one has some passing interest for the substance of false advertising law. Monster & … Continue reading

Posted in Uncategorized | Tagged | Leave a comment

FDA/FTC Workshop on a Competitive Marketplace for Biosimilars

FDA Licensure Process and U.S. Biosimilar Markets   [I entered in media res] · Eva Temkin, Acting Director for Policy, Office of Therapeutic Biologics and Biosimilars,  CDER, FDA   · Christine Simmon, Executive Director, Biosimilars Council, AAM: barriers to entry for … Continue reading

Posted in Uncategorized | Tagged , , , , | Leave a comment

“better lives for hens” was puffery, but hen living conditions claims weren’t

Lugones v. Pete & Gerry’s Organic, LLC, No. 19 Civ. 2097 (KPF), 2020 WL 871521  (S.D.N.Y. Feb. 21, 2020 Plaintiffs alleged that they bought defendant’s eggs, branded as Nellie’s Free Range Eggs, based on false advertisements indicating that the hens … Continue reading

Posted in Uncategorized | Tagged , | Leave a comment